Sarah Heynemann

9PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)RehabilitationMolecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 07, 2026
Navigating Evidence Standards: Stakeholder Perspectives on External Controls and Randomization in Cancer Trials.

|Jul 04, 2025
Quality Survivorship Care for People Affected by Advanced or Metastatic Cancer: A Clinical Oncology Society of Australia Endorsement of the Joint Multinational Association of Supportive Care in Cancer and American Society of Clinical Oncology Care Standards and Practice Recommendations.

Nicolas H Hart, Michael Jefford, Bogda Koczwara

|Dec 20, 2023
Therapeutic misunderstandings in modern research.

Sarah Heynemann, Wendy Lipworth, Sue-Anne McLachlan

|Feb 27, 2023
Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era.

Julia Lai-Kwon, Sarah Heynemann, Nicolas H Hart

|Feb 23, 2023
When research becomes practice: the concept of the therapeutic misconception and challenges to consent in clinical trials.

Sarah Heynemann, Wendy Lipworth, Sue-Anne McLachlan

|Dec 23, 2022
Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy.

Sarah Heynemann, Vinay Vanguru, Stephen Adelstein

Pageof 2

Frequent Collaborators

2 joint publications

Julia Lai-Kwon

2 joint publications

Nicolas H Hart

2 joint publications

Raymond J Chan

2 joint publications

Larissa Nekhlyudov